Professor Xiaobo Zhou

Partner, Healthcare

  • Professor Xianbo Zhou (MD, PhD) has over 27 years research experience (biochemistry, molecular and cellular biology) with 15+ years of industry managerial experience leading assay development, screening, in vitro/in vivo pharmacology, combined with vast drug discovery and development projects, managing large budgets.
  • Xianbo is currently Professor and Founding Director of the Center for Alzheimer’s Disease Research at Washington Institute of Clinical Research, Vienna, VA, USA.
  • He is also General Manager of SJN Biomed, Kunming, Yunnan, China, overseeing drug discovery and development efforts in the fields of anti-aging, CNS and oncology with initial focus on Alzheimer’s disease as well as oncology, and is managing collaboration with MemTrax LLC to bring MemTrax memory test product to the Chinese market place.
  • Xianbo is experienced in biotech start-up from the beginning: setting-up state-of-the-art molecular, cellular biology, high throughput screening and Drug Metabolism and Pharmacokinetics (DMPK) laboratories and establishing chemical hygiene and biosafety programs.
  • Established a wholly-foreign owned enterprise in Kunming, China from registration, facility renovation, hiring staff and having the company fully operational within 5 months from date of registration.


  • Xiaobo is experienced in identifying, selecting and dealing with contract research organizations (CROs) for both research and preclinical good laboratory practice (GLP) toxicity/safety studies for IND filing.
  • Participated in big pharmas’ due diligence of Aton Pharma as a part of Aton’s scientific team. Aton was acquired by Merck in 2004.
  • Participant on the team that developed the first-in-class histone deacetylase inhibitor Zolinza (vorinostat), which was approved in 2006.Board of Advisors, PEERChina (an NGO developing rural education projects in China).
  • 1997-2001, Postdoctoral training, Memorial Sloan-Kettering Cancer Center (MSKCC), New York.
  • 1991-1997, Ph.D., Biochemistry, State University of New York at Buffalo.
  • Thesis Title: Regulation of S-Adenosylhomocysteine Hydrolase Levels by Copper, Growth and During Development.
  • 1984-1990, Bachelor of Medicine (M.D. equivalent), Beijing Medical University (now Peking University Health Science Center), Beijing, China.
  • Chinese Associate of Medicine and Rehabilitation, Beijing, China.

Head Office

Ample Luck International Group Ltd.,
3/F, The Bund Panorama
108 Huangpu Road
Postcode: 200080
Phone: +1-203-508-2268

Drop a line